Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cyclins | 0.002 | 0.1443 | 0.1267 |
Echinococcus multilocularis | cyclins | 0.002 | 0.1443 | 0.1267 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0048 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0048 | 1 | 1 |
Echinococcus granulosus | cyclins | 0.002 | 0.1443 | 0.1267 |
Echinococcus multilocularis | cyclin b3 | 0.002 | 0.1443 | 0.1267 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0048 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.002 | 0.1443 | 0.1267 |
Echinococcus multilocularis | cyclins | 0.002 | 0.1443 | 0.1267 |
Schistosoma mansoni | lamin | 0.0033 | 0.5282 | 0.4486 |
Echinococcus multilocularis | cyclin B3 1 | 0.002 | 0.1443 | 0.1267 |
Trichomonas vaginalis | cyclins, putative | 0.0048 | 0.9808 | 0.9776 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0048 | 1 | 1 |
Giardia lamblia | Kinase, CMGC CDK | 0.0048 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0048 | 1 | 1 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0048 | 0.9808 | 0.9776 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.0048 | 1 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0048 | 0.9808 | 0.9776 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.002 | 0.1443 | 0.1267 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.5102 | 0.5091 |
Schistosoma mansoni | cyclin B | 0.0048 | 0.9808 | 0.9776 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.3828 | 0.3815 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0048 | 1 | 1 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0048 | 1 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.5282 | 0.4914 |
Echinococcus granulosus | lamin | 0.0033 | 0.5282 | 0.5185 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.5282 | 0.4914 |
Plasmodium falciparum | protein kinase 5 | 0.0048 | 1 | 1 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0048 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0048 | 1 | 1 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.0048 | 1 | 1 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.002 | 0.1443 | 0.1267 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.5282 | 0.4486 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0048 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.5282 | 0.5271 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0048 | 1 | 1 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0048 | 0.9808 | 0.9793 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0048 | 1 | 1 |
Echinococcus granulosus | cyclin B3 1 | 0.002 | 0.1443 | 0.1267 |
Trichomonas vaginalis | cyclin B, putative | 0.0048 | 0.9808 | 0.9776 |
Echinococcus granulosus | cyclins | 0.002 | 0.1443 | 0.1267 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.5282 | 0.5271 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.0723 | 0.0703 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0048 | 1 | 1 |
Echinococcus granulosus | cyclin B | 0.0048 | 0.9808 | 0.9804 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.0048 | 1 | 1 |
Echinococcus granulosus | cyclins | 0.002 | 0.1443 | 0.1267 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0048 | 1 | 1 |
Echinococcus multilocularis | musashi | 0.0033 | 0.5282 | 0.5185 |
Echinococcus multilocularis | cyclins | 0.002 | 0.1443 | 0.1267 |
Trichomonas vaginalis | cyclin A, putative | 0.0048 | 0.9808 | 0.9776 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.5282 | 0.5271 |
Trichomonas vaginalis | cyclin B, putative | 0.0048 | 0.9808 | 0.9776 |
Echinococcus multilocularis | cyclin B | 0.0048 | 0.9808 | 0.9804 |
Toxoplasma gondii | cell-cycle-associated protein kinase CDK, putative | 0.0048 | 1 | 1 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0048 | 1 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.5282 | 0.5185 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0048 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.002 | 0.1443 | 0.1267 |
Plasmodium vivax | protein kinase Crk2 | 0.0048 | 1 | 0.5 |
Echinococcus granulosus | cyclin dependent kinase | 0.0048 | 1 | 1 |
Giardia lamblia | Kinase, CMGC CDK | 0.0048 | 1 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.0048 | 0.9808 | 0.9776 |
Schistosoma mansoni | lamin | 0.0033 | 0.5282 | 0.4486 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.002 | 0.1443 | 0.1424 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0048 | 0.9808 | 0.9793 |
Entamoeba histolytica | cyclin, putative | 0.0048 | 0.9808 | 0.9776 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0048 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.9808 | 0.9807 |
Trichomonas vaginalis | cyclins, putative | 0.0048 | 0.9808 | 0.9776 |
Trichomonas vaginalis | cyclin B, putative | 0.0048 | 0.9808 | 0.9776 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0048 | 1 | 1 |
Echinococcus multilocularis | lamin | 0.0033 | 0.5282 | 0.5185 |
Trichomonas vaginalis | cyclins, putative | 0.0033 | 0.5271 | 0.4474 |
Echinococcus granulosus | cyclins | 0.002 | 0.1443 | 0.1267 |
Echinococcus granulosus | cyclin b3 | 0.002 | 0.1443 | 0.1267 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0048 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0048 | 1 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.5282 | 0.5185 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.5282 | 0.5185 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0048 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.002 | 0.1443 | 0.1267 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.9808 | 0.9807 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0202 | 0.018 |
Trichomonas vaginalis | cyclins, putative | 0.0048 | 0.9808 | 0.9776 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.002 | 0.1443 | 0.0776 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.0048 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.9845 | 0.9844 |
Echinococcus granulosus | cyclins | 0.002 | 0.1443 | 0.1267 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0048 | 1 | 1 |
Onchocerca volvulus | 0.0048 | 0.9808 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.0126 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.3548 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.